Compared to other cancers with established biomarkers, such as PR, ER and HER-2 in breast cancer 12 and RAS, BRAF, MMR in colon cancer 13, PDAC lacks effective markers to assist in diagnosis, treatment and prognosis. This evidence concerns the gene MRC1 and malignant colon neoplasm.